Supplement – Supplemental material for Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study

<p>Supplemental material, Supplement for Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study by Craig S. Jabaley, Francis A. Wolf, Grant C. Lynde and Vikas N. O’Reilly-Shah in Therapeutic Advances in Drug Safety</p